These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2128442)

  • 21. Bioavailability of ciprofloxacin and fleroxacin: results of a preliminary investigation in healthy adult Nigerian male volunteers.
    Chukwuani CM; Coker HA; Oduola AM; Sowunmi A; Ifudu ND
    Biol Pharm Bull; 2000 Aug; 23(8):968-72. PubMed ID: 10963305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fleroxacin: safety, tolerance and effect on the faecal flora of healthy volunteers.
    Shah PM; Sammann A; Schäfer V; Seczendi M; Knothe H
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():209-13. PubMed ID: 3144539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-dose pharmacokinetic study of ciprofloxacin and fleroxacin in healthy adult Nigerian volunteers.
    Chukwuani CM; Coker HA; Oduola AM; Ifudu ND; Sowunmi A
    Chemotherapy; 1998; 44(6):369-76. PubMed ID: 9755295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal tolerance of fleroxacin in healthy volunteers.
    Mondorf AW; Buch A; Steinbacher G; Rüdel C; Falkenberg FW
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():179-89. PubMed ID: 2904925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-dose pharmacokinetics of oral fleroxacin in bacteremic patients.
    Schrenzel J; Cerruti F; Herrmann M; Leemann T; Weidekamm E; Portmann R; Hirschel B; Lew DP
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1219-24. PubMed ID: 8092817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quinolone pharmacokinetics and metabolism.
    Lode H; Höffken G; Boeckk M; Deppermann N; Borner K; Koeppe P
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():41-9. PubMed ID: 2124212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and tissue penetration of Ro 23-6240, a new trifluoroquinolone.
    Wise R; Kirkpatrick B; Ashby J; Griggs DJ
    Antimicrob Agents Chemother; 1987 Feb; 31(2):161-3. PubMed ID: 3105446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary excretion and bactericidal activities of a single oral dose of 400 milligrams of fleroxacin versus a single oral dose of 800 milligrams of pefloxacin in healthy volunteers.
    Naber KG; Theuretzbacher U; Kinzig M; Savov O; Sörgel F
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1659-65. PubMed ID: 9661000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of fleroxacin coadministered with theophylline to young and elderly volunteers.
    Parent M; St-Laurent M; LeBel M
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1249-53. PubMed ID: 2118328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and metabolism of single oral doses of trovafloxacin.
    Vincent J; Teng R; Dalvie DK; Friedman HL
    Am J Surg; 1998 Dec; 176(6A Suppl):8S-13S. PubMed ID: 9935250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and tissue penetration of fleroxacin after single and multiple 400- and 800-mg-dosage regimens.
    Panneton AC; Bergeron MG; LeBel M
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1515-20. PubMed ID: 3142338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fleroxacin concentrations in myometrium, ovary and fallopian tube.
    Portmann R; Hansz C; Stiglmayer R; Weidekamm E
    J Antimicrob Chemother; 1989 Apr; 23(4):662-4. PubMed ID: 2501273
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatobiliary elimination of trovafloxacin and metabolites following single oral doses in healthy volunteers.
    Melnik G; Schwesinger WH; Teng R; Dogolo LC; Vincent J
    Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):424-6. PubMed ID: 9758286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of fleroxacin in renal impairment.
    Weidekamm E
    Am J Med; 1993 Mar; 94(3A):70S-74S. PubMed ID: 8452185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The role of ciprofloxacine metabolites in its biliary and urinary elimination in man].
    Brogard JM; Jehl F; Blickle JF; Arnaud JP; Monteil H
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):719-23. PubMed ID: 3054754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biliary excretion of rufloxacin in humans.
    Privitera G; Nicastro G; Imbimbo BP; Cesana M; Visconti M; Lombardi F; Tagliabue G; Faleschini E; Colturani F; Franzini P
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2545-9. PubMed ID: 8109915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of azosemide in patients with T-drain after cholecystectomy.
    Schuchmann HW; Rösch W; Koch U; Maurer HH; Stengl U; Mutschler E
    Arzneimittelforschung; 1992 Jun; 42(6):812-4. PubMed ID: 1418035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of Ro 23-9424, a dual-action cephalosporin, in animals.
    Christenson JG; Chan KK; Cleeland R; Dix-Holzknecht B; Farrish HH; Patel IH; Specian A
    Antimicrob Agents Chemother; 1990 Oct; 34(10):1895-900. PubMed ID: 2127171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple-dose pharmacokinetics and safety of oral amifloxacin in healthy volunteers.
    Cook JA; Silverman MH; Schelling DJ; Nix DE; Schentag JJ; Brown RR; Stroshane RM
    Antimicrob Agents Chemother; 1990 Jun; 34(6):974-9. PubMed ID: 2393295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of [18F]fleroxacin in patients with acute exacerbations of chronic bronchitis and complicated urinary tract infection studied by positron emission tomography.
    Fischman AJ; Livni E; Babich JW; Alpert NM; Bonab A; Chodosh S; McGovern F; Kamitsuka P; Liu YY; Cleeland R; Prosser BL; Correia JA; Rubin RH
    Antimicrob Agents Chemother; 1996 Mar; 40(3):659-64. PubMed ID: 8851589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.